Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Influenza infection and heart failure-vaccination may change heart failure prognosis?

Kadoglou NPE, Bracke F, Simmers T, Tsiodras S, Parissis J.

Heart Fail Rev. 2017 May;22(3):329-336. doi: 10.1007/s10741-017-9614-7. Review.

2.

Comparison of Side Effects of the 2015-2016 High-Dose, Inactivated, Trivalent Influenza Vaccine and Standard Dose, Inactivated, Trivalent Influenza Vaccine in Adults ≥65 Years.

Kaka AS, Filice GA, Myllenbeck S, Nichol KL.

Open Forum Infect Dis. 2017 Jan 12;4(1):ofx001. doi: 10.1093/ofid/ofx001. eCollection 2017 Winter.

3.

Healthcare maintenance in elderly patients with inflammatory bowel disease.

Shrestha MP, Ruel J, Taleban S.

Ann Gastroenterol. 2017;30(3):273-286. doi: 10.20524/aog.2017.0130. Epub 2017 Feb 17. Review.

4.

Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly.

Seo YB, Choi WS, Lee J, Song JY, Cheong HJ, Kim WJ.

Clin Exp Vaccine Res. 2017 Jan;6(1):38-44. doi: 10.7774/cevr.2017.6.1.38. Epub 2017 Jan 25.

5.

Postviral Complications: Bacterial Pneumonia.

Prasso JE, Deng JC.

Clin Chest Med. 2017 Mar;38(1):127-138. doi: 10.1016/j.ccm.2016.11.006. Epub 2016 Dec 13. Review.

PMID:
28159155
6.

Costs associated with influenza-related hospitalization in the elderly.

Torner N, Navas E, Soldevila N, Toledo D, Navarro G, Morillo A, Pérez MJ, Domínguez A; Working Group of the Project PI12/02079.

Hum Vaccin Immunother. 2017 Feb;13(2):412-416. doi: 10.1080/21645515.2017.1264829. Epub 2016 Dec 7.

PMID:
27925855
7.
8.

Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes.

Vamos EP, Pape UJ, Curcin V, Harris MJ, Valabhji J, Majeed A, Millett C.

CMAJ. 2016 Oct 4;188(14):E342-E351. Epub 2016 Jul 25.

9.

Use of Seasonal Influenza Vaccination and Its Associated Factors among Elderly People with Disabilities in Taiwan: A Population-Based Study.

Chang YC, Tung HJ, Hsu SW, Chen LS, Kung PT, Huang KH, Chiou SJ, Tsai WC.

PLoS One. 2016 Jun 23;11(6):e0158075. doi: 10.1371/journal.pone.0158075. eCollection 2016.

10.

The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial.

Sribhutorn A, Phrommintikul A, Wongcharoen W, Chaikledkaew U, Eakanunkul S, Sukonthasarn A.

Cardiol Res Pract. 2016;2016:4097471. doi: 10.1155/2016/4097471. Epub 2016 Apr 20.

11.

Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Esposito S, Bonanni P, Maggi S, Tan L, Ansaldi F, Lopalco PL, Dagan R, Michel JP, van Damme P, Gaillat J, Prymula R, Vesikari T, Mussini C, Frank U, Osterhaus A, Celentano LP, Rossi M, Guercio V, Gavazzi G.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1777-94. doi: 10.1080/21645515.2016.1150396. Epub 2016 May 2.

12.

Influenza Vaccination Coverage Rate according to the Pulmonary Function of Korean Adults Aged 40 Years and Over: Analysis of the Fifth Korean National Health and Nutrition Examination Survey.

Cha SH, Paik JH, Lee MR, Yang H, Park SG, Jeon YJ, Yoo S.

J Korean Med Sci. 2016 May;31(5):709-14. doi: 10.3346/jkms.2016.31.5.709. Epub 2016 Mar 25.

13.

Protective Effect of Hand-Washing and Good Hygienic Habits Against Seasonal Influenza: A Case-Control Study.

Liu M, Ou J, Zhang L, Shen X, Hong R, Ma H, Zhu BP, Fontaine RE.

Medicine (Baltimore). 2016 Mar;95(11):e3046. doi: 10.1097/MD.0000000000003046.

14.

A Matched Influenza Vaccine Strain Was Effective in Reducing the Risk of Acute Myocardial Infarction in Elderly Persons: A Population-Based Study.

Hsu SY, Chen FL, Liaw YP, Huang JY, Nfor ON, Chao DY.

Medicine (Baltimore). 2016 Mar;95(10):e2869. doi: 10.1097/MD.0000000000002869.

15.

The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.

Lund JL, Richardson DB, Stürmer T.

Curr Epidemiol Rep. 2015 Dec;2(4):221-228. Epub 2015 Sep 30.

16.

Factors Associated with Influenza Vaccination of Hospitalized Elderly Patients in Spain.

Domínguez À, Soldevila N, Toledo D, Godoy P, Castilla J, Force L, Morales M, Mayoral JM, Egurrola M, Tamames S, Martín V, Astray J; Working Group of the Project PI12/02079.

PLoS One. 2016 Jan 29;11(1):e0147931. doi: 10.1371/journal.pone.0147931. eCollection 2016.

17.

Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1.

Jiang J, Fisher EM, Concannon M, Lustigman S, Shen H, Murasko DM.

Vaccine. 2016 Feb 10;34(7):887-92. doi: 10.1016/j.vaccine.2016.01.003. Epub 2016 Jan 13.

18.

Influenza vaccination in the elderly: why are the overall benefits still hotly debated?

Trucchi C, Paganino C, Orsi A, De Florentiis D, Ansaldi F.

J Prev Med Hyg. 2015 Jun 10;56(1):E37-43. Review.

19.

The Saudi Thoracic Society guidelines for influenza vaccinations.

Zeitouni MO, Al Barrak AM, Al-Moamary MS, Alharbi NS, Idrees MM, Al Shimemeri AA, Al-Hajjaj MS.

Ann Thorac Med. 2015 Oct-Dec;10(4):223-30. doi: 10.4103/1817-1737.167065.

20.

Strategies for Early Vaccination During Novel Influenza Outbreaks.

Laskowski M, Xiao Y, Charland N, Moghadas SM.

Sci Rep. 2015 Dec 14;5:18062. doi: 10.1038/srep18062.

Supplemental Content

Support Center